US Threatens 250% Rise in Pharma Tariffs, India Tariff Blitz | The Opening Trade 8/6/2025August 6, 2025
US Threatens 250% Rise in Pharma Tariffs, India Tariff Blitz | The Opening Trade 8/6/2025August 6, 2025
BIG BANK CRACKDOWN: This should NEVER come up in banking conversations, says former GOP senatorAugust 6, 2025
‘ENTITLED’: GOP rep highlights the left’s beliefs after being criticized at his town hallAugust 6, 2025
Trump Tariff Threats Ramp Up; Israel Mulls Gaza Takeover | Horizons Middle East & Africa 8/6/2025August 6, 2025
Trump Ramps up Tariff Threats, Swiss President Dashes to Washington | Daybreak Europe 8/06/2025August 6, 2025
Share Facebook Twitter LinkedIn Pinterest Email Evan David Seigerman, BMO Capital Markets managing director & healthcare head, joins CNBC’s ‘Squawk on the Street’ to discuss outlooks on Pfizer.
